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We have synthesized a spin-label analog of phenylalanine as a competitive inhibitor probe of the sickle 
hemoglobin aggregation process. Sickle hemoglobin gelation measurements indicate that the spin-label 
phenyialanine analog is a potent inhibitor of deoxy sickle hemoglobin aggregation. We have also used spin 
label EPR and high-resolution proton NMR to study the interaction of the phenylalanine analog with 
hemoglobin, and find that the kinetic off-rate is comparable to, or slower than the hemoglobin rotational 
rate (i.e., z 10’ s-l), and that at least one, and perhaps two significant localized interaction region(s) exist 
within a few angstroms of the fi chain N- and C-termini. CorreIation with other known structural 
information suggests that the observed interaction sites may be relevant to the mechanism for inhibition 
of sickle hemoglobin aggregation. 
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1. INTRODUCTION 
Recent studies have shown the existence of a 
binding interaction between Hb and a variety of 
small molecules with hydrophobic moieties [l-8]. 
NMR studies have shown that several benzene 
derivatives exhibit weak, but specific binding to 
COHb, deoxy Hb and metHb [ 1,2]. Relaxation 
studies indicate that an aromatic binding site is 
within a few angstroms of the heme iron, but no 
detailed binding site has been proposed [I]. Several 
small molecules containing a variety of hydropho- 
bic moieties also inhibit the aggregation or gelation 
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Abbreviations: Hb, hemoglobin; COHb, carbonmonoxy 
liganded ferrous Hb; metHb, ferric Hb; HbA, normal 
adult Hb; HbS, sickle Hb; Tempone, 2,2,6,6-tetrameth- 
yl-Coxopiperidone-1-oxyl; SL-Phe, N-(2,2,5,5-tetra- 
methylpyrrolidin-l-oxyl-3-carboxyl)-L-phenylalanine t- 
butyl ester; Phe, phenylalanine; Cys, cysteine; Bis-Tris, 
[bis(2-hydroxyethyl)imino]tris(hydroxymethyl)methane 
of deoxygenated HbS through noncovalent inter- 
actions (3-71. The relative hydrophobicity of an 
agent appears to be the dominant characteristic in 
determining its effectiveness as an aggregation 
inhibitor [5]. These agents appear to act by a com- 
petitive binding mechanism in which the inhibitor 
binds to the HbS molecule at a crucial intermole- 
cular contact site, and prevents the association of 
two HbS molecules at that site. Recent X-ray crys- 
tallographic studies of COHb and deoxy Hb co- 
crystaIlized with several aromatic aggregation in- 
hibitors have suggested the existence of binding 
sites near al4 Trp, and in the internal cavity be- 
tween the subunits [8]. To elucidate further the 
binding site for these small molecules under solu- 
tion conditions, we have recently used conven- 
tionai and spin label-induced NMR relaxation to 
study the interaction of phenylalanine with 
COHbS [9]. We found that Phe exhibits weak 
binding to Hb, and that a binding site is probably 
located within about 10 f 3 A of the nitroxide free 
electron of hemoglobin that is spin-labeled at the 
fl93 Cys residues [9]. This is consistent with the 
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binding site being located within the lateral contact 
site that is complementary to the p6 mutation site 
within the deoxy HbS polymer structure [3,10]. 
Here, we report spin label EPR and high- 
resolution NMR measurements on the binding of a 
spin label analog of Phe (SL-Phe) to COHbS. The 
EPR data indicate that SL-Phe exhibits moderate 
binding to Hb, with a binding residence time com- 
parable to, or longer than the rotational correla- 
tion time of Hb. The NMR data suggest hat there 
is at least one, and perhaps two significant interac- 
tion region(s) close to thep2 His and/3146 residues 
on the Hb surface. Both of these residues are close 
to important HbS-HbS intermolecular contact 
sites [lo], thus the interaction may be significant 
for the action of Phe and related molecules as HbS 
aggregation inhibitors. 
2. MATERIALS AND METHODS 
Sickle blood samples were obtained from 
homozygous donors, and Hb composition was 
checked by electrophoresis. Samples containing 
more than trace amounts (5%) of HbA or fetal Hb 
were discarded. Blood samples of HbA were ob- 
tained from the University of Illinois Hospital 
Blood Bank. Membr~e-free HbA and HbS were 
prepared from the blood samples as in [I 11, and 
kept under CO atmosphere until use. The Hb solu- 
tions used in EPR studies were further purified by 
running through a Sephadex G-25 column with 
0.15 M Na-PO, buffer at pH 7.2. The spin probe, 
Tempone, was purchased from Eastman, and SL- 
Phe was synthesized in our laboratory; details of 
the synthesis will be published elsewhere. 
Measurements of the deoxy HbS gelation in- 
hibitory effectiveness of Phe and SL-Phe were per- 
formed using the ultracentrifugation C&t assay 
described in [12] at 20°C. 
For EPR measurements, samples containing 
0.1 mM Tempone or SL-Phe and COHb at a con- 
centration of about 30 g/d1 in 0.15 M Na-PO4 buf- 
fer at pH 7.2 were prepared under Nz atmosphere 
and loaded into 50-~1 capillary pipettes. Conven- 
tional first harmonic EPR spectra were measured 
at 20 mW microwave power, 100 G sweep width 
and 2 G modulation amplitude on a Varian E-4 
spectrometer at 25 ’ C . 
Organic phosphate was removed from Hb 
samples as in [ 131. All solutions for NMR studies 
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were treated with Chelex 100 (BioRad) to remove 
paramagnetic ions [9]. The Hb solutions were then 
exchanged 5 times with 0.1 M Bis-Tris buffer in 
DzO, to suppress the intense Hz0 proton 
resonance in the ‘H NMR spectrum. All glassware 
was soaked in alkaline EDTA solution overnight 
and washed with distilled, deionized water to 
remove paramagnetic ions. COHb solutions at a 
concentration of 10 g/dl, containing 0.5 mM Tem- 
pone or SL-Phe, were prepared under Nz at- 
mosphere and loaded into NMR tubes. The final 
pH of the samples was 7.4; values are given here as 
direct pH meter readings, without correcting for 
the deuterium isotope effect on the glass electrode, 
namely pD = pH + 0.4 [14]. The accuracy of each 
pH measurement was estimated to be + 0.02 pH 
unit. ‘H NMR spectra were obtained by the rapid- 
scan cross-correlation technique [ 151 on a Nicolet 
360 MHz spectrometer at a probe temperature of 
21°C. The spectrometer was locked on the D20 
signal in each sample. The sweep width was 
1800 Hz, with a sweep time of 5 s and a predelay 
time of 1 s. 
3. RESULTS AND DISCUSSION 
The ratios of deoxy HbS solubility in the 
presence of gelation inhibitor (SL-Phe or Phe) to 
the solubility in the absence of any inhibitors, 
Cr/Co, at various inhibitor concentrations are 
shown in fig. 1. The slope of the ratio, CI/CO, as 
a function of increasing inhibitor concentration, 
ioz 
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Fig-l. Deoxy HbS solubility ratio, G/Co, as a function 
of added SL-Phe or Phe. Cr is the deoxy HbS solubility 
in the presence of the gelation inhibitor, while Co is the 
solubility in the absence of inhibitor. The ratio has been 
assumed to be directly proportional to inhibitor 
concentrations and to have a value of 1 .O in the absence 
of inhibitor. The slope is a measure of the effectiveness 
of the inhibitor. 
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can be taken as a measure of the inhibitor effec- 
tiveness. The data of fig.1 indicate that the spin- 
labeled Phe analog is about 1%times more potent 
than Phe as an inhibitor of deoxy HbS gelation. 
This increase in inhibitory effectiveness is probably 
largely the result of the enhanced hydrophobic 
character of the Phe analog. 
EPR spectra of SL-Phe alone in solution and in 
the presence of COHbS, and of Tempone in the 
presence of COHbS are shown in fig.2. For SL- 
Phe in solution without any Hb, the spectrum is 
the simple 3-line pattern expected for a nitroxide 
tumbling freely in solution. For SL-Phe in the 
presence of COHbS, an additional spectral compo- 
nent characteristic of slow rotational tumbling 
(7r = 10-7-10-8 s) appears in the spectrum. The 
only change in solution condition is the addition of 
protein, thus the slow motion component must 
result from SL-Phe bound to Hb. A solution of 
Tempone plus Hb under the same conditions yields 
only the sharp 3-line fast motion spectrum, thus 
the binding of SL-Phe to Hb is also a consequence 
of the structure of the Phe analog, rather than of 
non-specific nitroxide binding to Hb. Taken 
together, these results indicate that SL-Phe ex- 
TemponetHbS-CO 
Fig.2. (Top) EPR spectrum of 0.1 mM SL-Phe in 
solution. (Center) EPR spectrum of 0.1 mM SL-Phe 
plus 30 g/d1 COHbS in solution. (Bottom) EPR 
spectrum of 0.1 mM Tempone plus 30 g/d1 COHbS in 
solution. Buffer conditions are as noted in the text. 
hibits specific binding to Hb, and that the 
residence time for at least one binding site must be 
comparable to, or longer than the Hb rotational 
correlation time [rr (Hb) 2: 30 ns]. 
‘H NMR spectra of the aromatic resonances for 
COHbS alone in solution, in the presence of SL- 
Phe, and in the presence of Tempone are shown in 
fig.3. Resonances for the C2 and C4 protons of p2 
His, and for the C2 proton of ,8146 His have been 
previously assigned [161, and are labeled in the top 
spectrum. Labeling of resonances follows the pat- 
tern given by [16]. Addition of 0.5 mM Tempone 
to the Hb sample produces perhaps a small amount 
of general ine broadening, but no specific changes 
in the spectrum, suggesting that the small nitroxide 
exhibits no specific interaction with Hb - consis- 
tent with the EPR results discussed above. Upon 
adding 0.5 mM SL-Phe to the system, however, 
very substantial spectral changes take place. 
Resonances C, G, P and S are almost totally sup- 
pressed, and other resonances are moderately 
c2 Prolo” 
CO-HbS 
TemponetCO-HbS 
SL-Phet CO-HbS 
I ” ” I ” , 1, I,, r 
3.5 3.0 25 2 0 Pm 
Fig.3. (Top) ‘H NMR spectrum of 10 g/d1 COHbS in 
solution. Labeling and assignment of ,82 and ,8146 
resonances are taken from [15]. (Center) ‘H NMR 
spectrum of 10 g/d1 COHbS plus 0.5 mM Tempone in 
solution. (Bottom) ‘H NMR spectrum of 10 g/d1 
COHbS plus 0.5 mM SL-Phe in solution. Buffer 
conditions are as noted in the text. 
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broadened, This is essentially the behavior to be 
expected if SL-Phe interacts with Hb at one or 
more localized regions. Resonances arising from 
protons located close to the interaction region(s) 
will experience strong paramagneti~ally induced 
relaxation from the fluctuating electron 
paramagnet of the nitroxide, and may be broad- 
ened enough to be no longer detectable [17]. 
Resonances arising from protons located farther 
from the interaction regions would be broadened 
much less due to the re6 distance dependence of 
paramagnetically induced relaxation. 
Resonances G and S arise from the C2 and C4 
protons, respectively, of fi2 His, thus SL-Phe ap- 
parently interacts with the Hb surface at a location 
within a few angstroms of the P-chain N-terminus. 
Resonance C arises from the C2 proton of 8146 
His, thus SL-Phe apparently also interacts with the 
Hb surface at a location within a few angstroms of 
the o-chain C-terminus. 
Resonance P may also be from a His C4 proton, 
but has not been assigned to a specific residue. Its 
disappearance in the presence of SL-Phe suggests 
either that it is also from a residue located near the 
‘p2’ or ‘,&46’ regions, or that another interaction 
site exists. 
The sickle hemoglobin mutation results in the 
substitution of valine for glutamic acid at the ,&6 
position. Thus, the SL-Phe binding site that is near 
a2 His is probably also in close proximity to the 
mutation site, and may well play a role in the in- 
hibition of HbS aggregation. Within the Hb 
molecule, the two p chains, pi and P2, are oriented 
~antipar~lel’ to each other, with the& N-terminus 
close to the,& C-terminus, and vice versa. The side 
chain imidazole rings of the Pi2 and ,&146 His 
residues are located within about IO-12 A of each 
other (as are those of the pi146 and ,&2 His 
residues) [181. Thus interaction of SL-Phe with Hb 
at a single local region that is close to both the ,&2. 
and ,&I46 His residues could produce suppression 
of resonances C, G and S (and perhaps P). 
However, the C-terminal P146 His residue is also 
located near the F helix region of the ,& chain, and 
is within about lo-15 A of the @85 Phe, ,&88 Leu 
and pS1 Leu residues that we previously proposed 
as a binding site for small hydrophobic molecules 
[9]. The relatively long binding residence time sug- 
gested by the EPR spectra of fig. 1 would probably 
be sufficient to induce suppression of the @I46 His 
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resonances. Thus another significant interaction 
region for SL-Phe may also exist. This region ap- 
pears to be an important HbS-HbS intermolecular 
contact region [lo], thus interaction at this loca- 
tion may also play a role in the inhibition of deoxy 
HbS gelation. Authors in [8] have also suggested 
that binding of aromatic gelation inhibitors may 
occur near cyl4 Trp, and at sites in the internal 
cavity between subunits, thus interaction at several 
sites may be possible. 
In previous work we have shown that even fully 
carbon monoxide liganded HbS exhibits a limited 
aggregation under some conditions, with such ag- 
gregation presumably continuing upon deoxygena- 
tion to produce the commonly observed polymer 
structures [19,20]. The binding behavior observed 
here appears to be fully consistent with a com- 
petitive binding mechanism for inhibition of HbS 
gelation, however more detailed studies including 
liganded and deoxy forms of both HbA and HbS 
will be required to elucidate fully inhibitor binding 
sites for the liganded and unliganded states, and to 
determine those sites that are important under 
solution conditions. 
In summary, we have synthesized a spin-labeled 
analog of phenylalanine that inhibits deoxy HbS 
aggregation about two orders of magnitude better 
than the parent amino acid. EPR measurements in- 
dicate that SL-Phe exhibits significant binding to 
COHbS, with a binding residue time that is long on 
the EPR time scale. NMR measurements suggest 
that one or two localized interaction regions are 
physically close to the ,f32 His and p146 His 
residues. 3inding near the p2 His should influence 
the p6 mutation site, and inhibit HbS gelation; 
binding near the,&46 His residue is consistent with 
our previous suggestion of a hydrophobic binding 
site being located in the cleft between the P-chain 
F helix and the heme [9], and may also play a role 
in the inhibition of HbS gelation. 
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